Trial Profile
A Phase 1 Crossover Study to Assess the Relative Bioavailability of Roxadustat Following a Single Dose of Pediatric Azo Dye-free Tablet and Pediatric Azo Dye-free Mini-tablet (Solid and Suspension) Compared to a Single Dose of Azo Dye-containing Tablet in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Oct 2020
Price :
$35
*
At a glance
- Drugs Roxadustat (Primary) ; Roxadustat
- Indications Anaemia
- Focus Pharmacokinetics
- Sponsors Astellas Pharma Global Development
- 14 Nov 2019 Status changed from recruiting to completed.
- 01 Nov 2019 This trial has been completed in Germany, according to European Clinical Trials Database.
- 19 Jul 2019 Planned End Date changed from 1 Sep 2019 to 1 Oct 2019.